A
Axel Glasmacher
Researcher at Celgene
Publications - 151
Citations - 7147
Axel Glasmacher is an academic researcher from Celgene. The author has contributed to research in topics: Itraconazole & Neutropenia. The author has an hindex of 47, co-authored 147 publications receiving 6808 citations. Previous affiliations of Axel Glasmacher include University of Bonn & University of Giessen.
Papers
More filters
Journal ArticleDOI
Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy
Hendrik Pels,Ingo G.H. Schmidt-Wolf,Axel Glasmacher,Holger Schulz,Andreas Engert,Volker Diehl,Anton Zellner,Gabriele Schackert,Heinz Reichmann,Frank Kroschinsky,Marlies Vogt-Schaden,Gerlinde Egerer,Udo Bode,Carlo Schaller,Martina Deckert,Rolf Fimmers,Christoph Helmstaedter,Aslihan Atasoy,Thomas Klockgether,Uwe Schlegel +19 more
TL;DR: Primary chemotherapy based on high-dose MTX and ARA-C is highly efficient in PCNSL and response rate and response duration are comparable to the response rates and durations reported after combined radiotherapy and chemotherapy.
Journal ArticleDOI
Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients
Axel Glasmacher,Archibald G. Prentice,Marcus Gorschlüter,Steffen Engelhart,C. Hahn,Benjamin Djulbegovic,Ingo G.H. Schmidt-Wolf +6 more
TL;DR: Antifungal prophylaxis with itraconazole effectively prevents proven invasive fungal infections and is shown for the first time for antifungals-reduces mortality from these infections and the rate of invasive Aspergillus infections in neutropenic patients with hematologic malignancies.
Journal ArticleDOI
A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma.
Axel Glasmacher,C. Hahn,Florian Hoffmann,Ralph Naumann,Hartmut Goldschmidt,Marie von Lilienfeld-Toal,Katjana Orlopp,Ingo G.H. Schmidt-Wolf,Marcus Gorschlüter +8 more
TL;DR: Thalidomide monotherapy achieved complete and partial responses in 29·4% of patients with relapsed or refractory multiple myeloma.
Journal ArticleDOI
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
David I. Marks,Antonio Pagliuca,Christopher C. Kibbler,Axel Glasmacher,Claus Peter Heussel,Michal Kantecki,P. Miller,Patricia Ribaud,Haran T. Schlamm,Carlos Solano,Gordon Cook +10 more
TL;DR: Voriconazole was superior to itraconazole as antifungal prophylaxis after alloHCT, based on differences in the primary composite endpoint.
Journal ArticleDOI
Neutropenic enterocolitis in adults: systematic analysis of evidence quality.
Marcus Gorschlüter,Ulrich Mey,John Strehl,Carsten Ziske,Michael Schepke,Ingo G.H. Schmidt-Wolf,Tilman Sauerbruch,Axel Glasmacher +7 more
TL;DR: This systematic review provides diagnostic criteria for neutropenic enterocolitis, presents a quantitative synthesis on its incidence and discusses its treatment recommendations.